Orbis Medicines

Orbis Medicines company information, Employees & Contact Information

Updated May 2026

Quick answer

Orbis Medicines is a Biotechnology Research company. It has approximately 39 employees on record. Contact data was last refreshed in May 2026. Find Orbis Medicines's verified employee emails, phone numbers, headquarters address, and key decision makers below.

Explore related pages

Related company profiles:

We are developing the future of drug discovery with a platform to discover, develop, and deliver drug candidates for challenging targets. Sign up for our quarterly newsletter to keep up with our progress: https://lnkd.in/eCH3d6ay

Company Details

Employees
39
Address
Copenhagen, Dk
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords
Hellerup.
HQ
Copenhagen
Looking for a particular Orbis Medicines employee's phone or email?

Orbis Medicines Questions

News

Orbis Medicines Raises EUR 90 Million Series A Funding Round to Develop Pipeline of Oral Macrocycles - Business Wire

Orbis Medicines Raises EUR 90 Million Series A Funding Round to Develop Pipeline of Oral Macrocycles Business Wire

Orbis Medicines Accelerates Next-Generation Oral Macrocycle Platform with Enhanced Artificial Intelligence Capabilities of Gefion Supercomputer - Yahoo Finance

Orbis Medicines Accelerates Next-Generation Oral Macrocycle Platform with Enhanced Artificial Intelligence Capabilities of Gefion Supercomputer Yahoo Finance

Orbis Medicines launches with €26 million seed financing to transform macrocycle drug development through next-generation orally dosable ‘nCycles’ - Arctic Today

Orbis Medicines launches with €26 million seed financing to transform macrocycle drug development through next-generation orally dosable ‘nCycles’ Arctic Today

Orbis Medicines to Expand With New R&D Site in Copenhagen - Business Wire

Orbis Medicines to Expand With New R&D Site in Copenhagen Business Wire

Startup Orbis Medicines Launches With €26M for Next-Generation Peptide Drugs - MedCity News

Startup Orbis Medicines Launches With €26M for Next-Generation Peptide Drugs MedCity News

Copenhagen’s Orbis Medicines raises €90M to advance oral drug discovery and appoints new CEO: Know more - Silicon Canals

Copenhagen’s Orbis Medicines raises €90M to advance oral drug discovery and appoints new CEO: Know more Silicon Canals

Orbis Medicines Names Veteran R&D Leader Mikael Dolsten Board Chair - Business Wire

Orbis Medicines Names Veteran R&D Leader Mikael Dolsten Board Chair Business Wire

15 Jahre Top100: Schweizer Startups im Rampenlicht und auf dem Weg zur Weltspitze - Moneycab

15 Jahre Top100: Schweizer Startups im Rampenlicht und auf dem Weg zur Weltspitze Moneycab

Top Orbis Medicines Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant